Citation Impact

Citing Papers

Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025
2020
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: Cosponsored by american association of clinical endocrinologists, The obesity society, and american society for metabolic & bariatric surgery*
2013 Standout
Niacin and fibrates in atherogenic dyslipidemia: Pharmacotherapy to reduce cardiovascular risk
2010
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
2012 Standout
Mobile Applications for Control and Self Management of Diabetes: A Systematic Review
2016 Standout
Type 1 diabetes
2013 Standout
Insulin-Pump Therapy for Type 1 Diabetes Mellitus
2012
American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis
2012
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review
2010
Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation
2010
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
2023 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout

Works of S Roze being referenced

Cost-effectiveness of sensor-augmented pump therapy versus standard insulin pump therapy in patients with type 1 diabetes in Denmark
2017
Cost-effectiveness of raising HDL cholesterol by adding prolonged-release nicotinic acid to statin therapy in the secondary prevention setting: a French perspective
2007
An economic evaluation of the Irbesartan in Diabetic Nephropathy Trial (IDNT) in a UK setting
2004
Health‐economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK
2005
Rankless by CCL
2026